Academic · Private company
Masonic Cancer Center, University of Minnesota
Track this companyFree. Adds Masonic Cancer Center, University of Minnesota to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With Trispecific Killer EngagersRECRUITING · started Oct 8, 2026ClinicalTrials.gov NCT07910019 · fetched Nov 12, 2026
- Rural Smoking CessationNA · RECRUITING · started Mar 17, 2026ClinicalTrials.gov NCT06584929 · fetched Nov 12, 2026
- LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal CancerNA · ACTIVE_NOT_RECRUITING · started Sep 9, 2025ClinicalTrials.gov NCT07153016 · fetched Nov 12, 2026
- HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZLPHASE2 · RECRUITING · started Aug 7, 2025ClinicalTrials.gov NCT06792825 · fetched Nov 12, 2026
- UNTOLD Ovarian Cancer Unmet Needs SurveyRECRUITING · started Jul 10, 2025ClinicalTrials.gov NCT07070726 · fetched Nov 12, 2026
- Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)PHASE1_PHASE2 · RECRUITING · started Jul 7, 2025ClinicalTrials.gov NCT07008638 · fetched Nov 12, 2026
- American Indian Smokefree Native RCTNA · RECRUITING · started Apr 14, 2025ClinicalTrials.gov NCT06544811 · fetched Nov 12, 2026
- MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin LymphomaPHASE2 · RECRUITING · started Dec 4, 2024ClinicalTrials.gov NCT06377540 · fetched Nov 12, 2026
- HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AMLPHASE1 · RECRUITING · started Nov 19, 2024ClinicalTrials.gov NCT06594445 · fetched Nov 12, 2026
- Allo HSCT for High Risk HemoglobinopathiesPHASE2 · RECRUITING · started Nov 19, 2024ClinicalTrials.gov NCT06872333 · fetched Nov 12, 2026
- Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking MeasuresNA · ACTIVE_NOT_RECRUITING · started Oct 12, 2024ClinicalTrials.gov NCT06295757 · fetched Nov 12, 2026
- Assessing the Time Demands of CancerACTIVE_NOT_RECRUITING · started Nov 13, 2023ClinicalTrials.gov NCT05708703 · fetched Nov 12, 2026
- Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer SurvivorsNA · ACTIVE_NOT_RECRUITING · started Jul 24, 2023ClinicalTrials.gov NCT05665543 · fetched Nov 12, 2026
- Allo HSCT Using RIC and PTCy for Hematological DiseasesPHASE2 · RECRUITING · started May 1, 2023ClinicalTrials.gov NCT05805605 · fetched Nov 12, 2026
- RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II TrialPHASE2 · RECRUITING · started Nov 30, 2022ClinicalTrials.gov NCT04105270 · fetched Nov 12, 2026
- Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.ACTIVE_NOT_RECRUITING · started Nov 17, 2022ClinicalTrials.gov NCT05634512 · fetched Nov 12, 2026
- Role of Acetaldehyde in the Development of Oral CancerNA · RECRUITING · started Jul 8, 2022ClinicalTrials.gov NCT05973656 · fetched Nov 12, 2026
- NF-1, Nutraceutical InterventionPHASE1 · ACTIVE_NOT_RECRUITING · started Jul 6, 2022ClinicalTrials.gov NCT05363267 · fetched Nov 12, 2026
- Myeloablative Allo HSCT With Related or Unrelated Donor for Heme DisordersPHASE2 · RECRUITING · started Mar 30, 2018ClinicalTrials.gov NCT03314974 · fetched Nov 12, 2026
- Auto Stem Cell Transplant for Lymphoma PatientsPHASE2 · RECRUITING · started Apr 20, 2017ClinicalTrials.gov NCT03125642 · fetched Nov 12, 2026
- Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk NeuroblastomaPHASE2 · RECRUITING · started Jun 1, 2016ClinicalTrials.gov NCT02605421 · fetched Nov 12, 2026
- MT2013-31: Allo HCT for Metabolic Disorders and Severe OsteopetrosisPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 10, 2014ClinicalTrials.gov NCT02171104 · fetched Nov 12, 2026
- Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune DeficienciesNA · ACTIVE_NOT_RECRUITING · started Sep 4, 2012ClinicalTrials.gov NCT01652092 · fetched Nov 12, 2026
- Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)NA · RECRUITING · started Aug 1, 2012ClinicalTrials.gov NCT01666080 · fetched Nov 12, 2026
- Infusion of Cell Populations From Unlicensed Umbilical Cord Blood UnitsNA · RECRUITING · started Oct 20, 2011ClinicalTrials.gov NCT01451502 · fetched Nov 12, 2026